Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1994 Sep;97(3):483–490. doi: 10.1111/j.1365-2249.1994.tb06114.x

Reduced interferon-gamma (IFN-gamma) secretion with increased IFN-gamma mRNA expression in atopic dermatitis: evidence for a post-transcriptional defect.

M L Tang 1, G Varigos 1, A S Kemp 1
PMCID: PMC1534845  PMID: 8082304

Abstract

Reduced secretion of IFN-gamma in atopic individuals has been implicated in the pathogenesis of disease, though the mechanisms leading to this reduced secretion have not been elucidated. As production of IFN-gamma has been shown to be predominantly regulated by its rate of transcription, expression of IFN-gamma mRNA was examined in atopic children and in age-matched, non-atopic controls by polymerase chain reaction (PCR)-assisted mRNA amplification. Children with atopic dermatitis were found to have constitutive expression of IFN-gamma mRNA in freshly isolated peripheral blood mononuclear cells (PBMC) and in unstimulated PBMC cultures which increased further following stimulation with phorbol myristate acetate (PMA)/Ca in vitro. In contrast, expression of IFN-gamma mRNA in controls was only detected in stimulated cultures, as has been demonstrated previously for normal adults. These findings demonstrate that circulating T cells from atopic children have been activated in vivo, and suggest that T cell activation is a significant component of the inflammatory process in atopic dermatitis. Although expression of IFN-gamma mRNA was increased in the atopic children, secretion was confirmed to be significantly lower than in controls, indicating that the defect(s) underlying reduced IFN-gamma secretion in these individuals lie post-transcriptionally.

Full text

PDF
486

Images in this article

485Fig. 1
on p.485
486Fig. 2
on p.486
487Fig. 3
on p.487
487Fig. 4
on p.487

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arya S. K., Wong-Staal F., Gallo R. C. Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. J Immunol. 1984 Jul;133(1):273–276. [PubMed] [Google Scholar]
  2. Boguniewicz M., Jaffe H. S., Izu A., Sullivan M. J., York D., Geha R. S., Leung D. Y. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med. 1990 Apr;88(4):365–370. doi: 10.1016/0002-9343(90)90490-5. [DOI] [PubMed] [Google Scholar]
  3. Bos J. D., Wierenga E. A., Sillevis Smitt J. H., van der Heijden F. L., Kapsenberg M. L. Immune dysregulation in atopic eczema. Arch Dermatol. 1992 Nov;128(11):1509–1512. [PubMed] [Google Scholar]
  4. Buchan G., Barrett K., Fujita T., Taniguchi T., Maini R., Feldmann M. Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma. Clin Exp Immunol. 1988 Feb;71(2):295–301. [PMC free article] [PubMed] [Google Scholar]
  5. Chan S. H., Kobayashi M., Santoli D., Perussia B., Trinchieri G. Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol. 1992 Jan 1;148(1):92–98. [PubMed] [Google Scholar]
  6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  7. Chopra R. K., Holbrook N. J., Powers D. C., McCoy M. T., Adler W. H., Nagel J. E. Interleukin 2, interleukin 2 receptor, and interferon-gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. Clin Immunol Immunopathol. 1989 Nov;53(2 Pt 1):297–308. doi: 10.1016/0090-1229(89)90058-5. [DOI] [PubMed] [Google Scholar]
  8. Colver G. B., Symons J. A., Duff G. W. Soluble interleukin 2 receptor in atopic eczema. BMJ. 1989 May 27;298(6685):1426–1428. doi: 10.1136/bmj.298.6685.1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Damle N. K., Leytze G., Klussman K., Ledbetter J. A. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism. Eur J Immunol. 1993 Jul;23(7):1513–1522. doi: 10.1002/eji.1830230718. [DOI] [PubMed] [Google Scholar]
  10. Efrat S., Pilo S., Kaempfer R. Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and gamma-interferon. Nature. 1982 May 20;297(5863):236–239. doi: 10.1038/297236a0. [DOI] [PubMed] [Google Scholar]
  11. Farrar M. A., Schreiber R. D. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol. 1993;11:571–611. doi: 10.1146/annurev.iy.11.040193.003035. [DOI] [PubMed] [Google Scholar]
  12. Fiorentino D. F., Bond M. W., Mosmann T. R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989 Dec 1;170(6):2081–2095. doi: 10.1084/jem.170.6.2081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gauchat J. F., Gauchat D., De Weck A. L., Stadler B. M. Cytokine mRNA levels in antigen-stimulated peripheral blood mononuclear cells. Eur J Immunol. 1989 Jun;19(6):1079–1085. doi: 10.1002/eji.1830190618. [DOI] [PubMed] [Google Scholar]
  14. Gauchat J. F., Gauchat D., Qiu G., Mandallaz M., Stadler B. M. Detection of cytokine mRNA in polyclonally-, antigen- or allergen-stimulated mononuclear cells. Immunol Rev. 1991 Feb;119:147–161. doi: 10.1111/j.1600-065x.1991.tb00582.x. [DOI] [PubMed] [Google Scholar]
  15. Handa K., Suzuki R., Matsui H., Shimizu Y., Kumagai K. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production. J Immunol. 1983 Feb;130(2):988–992. [PubMed] [Google Scholar]
  16. Hanifin J. M., Lobitz W. C., Jr Newer concepts of atopic dermatitis. Arch Dermatol. 1977 May;113(5):663–670. [PubMed] [Google Scholar]
  17. Hanifin J. M., Schneider L. C., Leung D. Y., Ellis C. N., Jaffe H. S., Izu A. E., Bucalo L. R., Hirabayashi S. E., Tofte S. J., Cantu-Gonzales G. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol. 1993 Feb;28(2 Pt 1):189–197. doi: 10.1016/0190-9622(93)70026-p. [DOI] [PubMed] [Google Scholar]
  18. Herrmann T., Baschieri S., Lees R. K., MacDonald H. R. In vivo responses of CD4+ and CD8+ cells to bacterial superantigens. Eur J Immunol. 1992 Jul;22(7):1935–1938. doi: 10.1002/eji.1830220739. [DOI] [PubMed] [Google Scholar]
  19. Hoeger P. H., Lenz W., Boutonnier A., Fournier J. M. Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis. 1992 Jun;165(6):1064–1068. doi: 10.1093/infdis/165.6.1064. [DOI] [PubMed] [Google Scholar]
  20. Jensen J. R., Sand T. T., Jørgensen A. S., Thestrup-Pedersen K. Modulation of natural killer cell activity in patients with atopic dermatitis. J Invest Dermatol. 1984 Jan;82(1):30–34. doi: 10.1111/1523-1747.ep12259055. [DOI] [PubMed] [Google Scholar]
  21. Jujo K., Renz H., Abe J., Gelfand E. W., Leung D. Y. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol. 1992 Sep;90(3 Pt 1):323–331. doi: 10.1016/s0091-6749(05)80010-7. [DOI] [PubMed] [Google Scholar]
  22. Kasahara T., Hooks J. J., Dougherty S. F., Oppenheim J. J. Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. J Immunol. 1983 Apr;130(4):1784–1789. [PubMed] [Google Scholar]
  23. Kobayashi M., Fitz L., Ryan M., Hewick R. M., Clark S. C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med. 1989 Sep 1;170(3):827–845. doi: 10.1084/jem.170.3.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kristensson K., Borrebaeck C. A., Carlsson R. Human CD4+ T cells expressing CD45RA acquire the lymphokine gene expression of CD45RO+ T-helper cells after activation in vitro. Immunology. 1992 May;76(1):103–109. [PMC free article] [PubMed] [Google Scholar]
  25. Krönke M., Leonard W. J., Depper J. M., Greene W. C. Sequential expression of genes involved in human T lymphocyte growth and differentiation. J Exp Med. 1985 Jun 1;161(6):1593–1598. doi: 10.1084/jem.161.6.1593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Leung D. Y., Bhan A. K., Schneeberger E. E., Geha R. S. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol. 1983 Jan;71(1 Pt 1):47–56. doi: 10.1016/0091-6749(83)90546-8. [DOI] [PubMed] [Google Scholar]
  27. Lewis D. B., Yu C. C., Meyer J., English B. K., Kahn S. J., Wilson C. B. Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J Clin Invest. 1991 Jan;87(1):194–202. doi: 10.1172/JCI114970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Maurer D., Felzmann T., Holter W., Petera P., Smolen J., Knapp W. Evidence for the presence of activated CD4 T cells with naive phenotype in the peripheral blood of patients with rheumatoid arthritis. Clin Exp Immunol. 1992 Mar;87(3):429–434. doi: 10.1111/j.1365-2249.1992.tb03014.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Moore K. W., Vieira P., Fiorentino D. F., Trounstine M. L., Khan T. A., Mosmann T. R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science. 1990 Jun 8;248(4960):1230–1234. doi: 10.1126/science.2161559. [DOI] [PubMed] [Google Scholar]
  30. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 1984 Apr 19;308(5961):693–698. doi: 10.1038/308693a0. [DOI] [PubMed] [Google Scholar]
  31. Parronchi P., Macchia D., Piccinni M. P., Biswas P., Simonelli C., Maggi E., Ricci M., Ansari A. A., Romagnani S. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4538–4542. doi: 10.1073/pnas.88.10.4538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pearlstein K. T., Palladino M. A., Welte K., Vilcek J. Purified human interleukin-2 enhances induction of immune interferon. Cell Immunol. 1983 Aug;80(1):1–9. doi: 10.1016/0008-8749(83)90088-6. [DOI] [PubMed] [Google Scholar]
  33. Peleman R., Wu J., Fargeas C., Delespesse G. Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells. J Exp Med. 1989 Nov 1;170(5):1751–1756. doi: 10.1084/jem.170.5.1751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pisa E. K., Pisa P., Hansson M., Wigzell H. OKT3-induced cytokine mRNA expression in human peripheral blood mononuclear cells measured by polymerase chain reaction. Scand J Immunol. 1992 Nov;36(5):745–749. doi: 10.1111/j.1365-3083.1992.tb03135.x. [DOI] [PubMed] [Google Scholar]
  35. Qiu G., Gauchat J. F., Wirthmüller U., De Weck A. L., Stadler B. M. Lymphokine production by human peripheral blood lymphocytes: analysis by in situ hybridization. Lymphokine Res. 1988 Winter;7(4):385–392. [PubMed] [Google Scholar]
  36. Reinhold U., Pawelec G., Wehrmann W., Kukel S., Oehr P., Kreysel H. W. Cytokine release from cultured peripheral blood mononuclear cells of patients with severe atopic dermatitis. Acta Derm Venereol. 1989;69(6):497–502. [PubMed] [Google Scholar]
  37. Reinhold U., Wehrmann W., Kukel S., Kreysel H. W. Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin Exp Immunol. 1990 Mar;79(3):374–379. doi: 10.1111/j.1365-2249.1990.tb08098.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Reinhold U., Wehrmann W., Kukel S., Kreysel H. W. Recombinant interferon-gamma in severe atopic dermatitis. Lancet. 1990 May 26;335(8700):1282–1282. doi: 10.1016/0140-6736(90)91347-d. [DOI] [PubMed] [Google Scholar]
  39. Rousset F., Robert J., Andary M., Bonnin J. P., Souillet G., Chrétien I., Brière F., Pène J., de Vries J. E. Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol. 1991 Jan;87(1 Pt 1):58–69. doi: 10.1016/0091-6749(91)90213-8. [DOI] [PubMed] [Google Scholar]
  40. Rutenfranz I., Kruse A., Kirchner H. In situ hybridization of interferon-gamma producing peripheral blood mononuclear cells. Scand J Immunol. 1991 Aug;34(2):169–178. doi: 10.1111/j.1365-3083.1991.tb01534.x. [DOI] [PubMed] [Google Scholar]
  41. Sadouk M., Vaquero C., de la Tour B., Amor B., Toubert A. Interferon-gamma mRNA expression upon in vitro T lymphocyte activation is decreased in rheumatoid arthritis patients. Clin Immunol Immunopathol. 1990 Jul;56(1):37–45. doi: 10.1016/0090-1229(90)90167-o. [DOI] [PubMed] [Google Scholar]
  42. Sandvig S., Laskay T., Andersson J., De Ley M., Andersson U. Gamma-interferon is produced by CD3+ and CD3- lymphocytes. Immunol Rev. 1987 Jun;97:51–65. doi: 10.1111/j.1600-065x.1987.tb00516.x. [DOI] [PubMed] [Google Scholar]
  43. Tang M., Kemp A. Production and secretion of interferon-gamma (IFN-gamma) in children with atopic dermatitis. Clin Exp Immunol. 1994 Jan;95(1):66–72. doi: 10.1111/j.1365-2249.1994.tb06016.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tang M., Kemp A., Varigos G. IL-4 and interferon-gamma production in children with atopic disease. Clin Exp Immunol. 1993 Apr;92(1):120–124. doi: 10.1111/j.1365-2249.1993.tb05957.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Taniguchi T. Regulation of cytokine gene expression. Annu Rev Immunol. 1988;6:439–464. doi: 10.1146/annurev.iy.06.040188.002255. [DOI] [PubMed] [Google Scholar]
  46. Thestrup-Pedersen K., Larsen C. S., Kristensen M., Zachariae C. Interleukin-1 release from peripheral blood monocytes and soluble interleukin-2 and CD8 receptors in serum from patients with atopic dermatitis. Acta Derm Venereol. 1990;70(5):395–399. [PubMed] [Google Scholar]
  47. Toshitani A., Ansel J. C., Chan S. C., Li S. H., Hanifin J. M. Increased interleukin 6 production by T cells derived from patients with atopic dermatitis. J Invest Dermatol. 1993 Mar;100(3):299–304. doi: 10.1111/1523-1747.ep12469875. [DOI] [PubMed] [Google Scholar]
  48. Truneh A., Albert F., Golstein P., Schmitt-Verhulst A. M. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature. 1985 Jan 24;313(6000):318–320. doi: 10.1038/313318a0. [DOI] [PubMed] [Google Scholar]
  49. Vercelli D., Jabara H. H., Lauener R. P., Geha R. S. IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol. 1990 Jan 15;144(2):570–573. [PubMed] [Google Scholar]
  50. Waalen K., Sioud M., Natvig J. B., Førre O. Spontaneous in vivo gene transcription of interleukin-2, interleukin-3, interleukin-4, interleukin-6, interferon-gamma, interleukin-2 receptor (CD25) and proto-oncogene c-myc by rheumatoid synovial T lymphocytes. Scand J Immunol. 1992 Dec;36(6):865–873. doi: 10.1111/j.1365-3083.1992.tb03148.x. [DOI] [PubMed] [Google Scholar]
  51. Wakasugi N., Virelizier J. L. Defective IFN-gamma production in the human neonate. I. Dysregulation rather than intrinsic abnormality. J Immunol. 1985 Jan;134(1):167–171. [PubMed] [Google Scholar]
  52. Wehrmann W., Reinhold U., Kukel S., Franke N., Uerlich M., Kreysel H. W. Selective alterations in natural killer cell subsets in patients with atopic dermatitis. Int Arch Allergy Appl Immunol. 1990;92(3):318–322. doi: 10.1159/000235196. [DOI] [PubMed] [Google Scholar]
  53. Wehrmann W., Reinhold U., Pawelec G., Wernet P., Kreysel H. W. In vitro generation of IFN-gamma in relationship to in vivo concentration of IgE and IgG subclasses and Fc epsilon Rl/CD23 positive circulating lymphocytes in patients with severe atopic dermatitis (AD). Acta Derm Venereol Suppl (Stockh) 1989;144:127–130. doi: 10.2340/00015555144127130. [DOI] [PubMed] [Google Scholar]
  54. Wierenga E. A., Snoek M., de Groot C., Chrétien I., Bos J. D., Jansen H. M., Kapsenberg M. L. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol. 1990 Jun 15;144(12):4651–4656. [PubMed] [Google Scholar]
  55. Wilson C. B., Westall J., Johnston L., Lewis D. B., Dower S. K., Alpert A. R. Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest. 1986 Mar;77(3):860–867. doi: 10.1172/JCI112383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wüthrich B., Joller-Jemelka H., Helfenstein U., Grob P. J. Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitis. Dermatologica. 1990;181(2):92–97. doi: 10.1159/000247893. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES